Results 171 to 180 of about 3,017,657 (309)

Beyond the First Impact Factor: Editorial Renewal and Direction in Thoracic Research and Practice. [PDF]

Thorac Res Pract
Akgün M, Ergan B.
europepmc   +1 more source

Dual PI3K/AKT and CDK4/6 inhibition reveals selective sensitivity in an SHH medulloblastoma stem cell model

Molecular Oncology, EarlyView.
Targeted therapy was evaluated in SHH medulloblastoma using neuroepithelial stem cell (NES) and tumor‐derived NES‐like (tNES) models in 2D monolayers and 3D spheroids. PI3K, AKT, and CDK4/6 inhibitors had minimal effects in NES but markedly reduced viability and growth and induced apoptosis in tNES cells, revealing distinct therapeutic vulnerabilities.
Monika Lukoseviciute, Madeleine Birgersson, Paolo Ceriani, Margareta Wilhelm, Ourania N Kostopoulou   +4 more
wiley   +1 more source

Detronizacija faktora utjecaja?! - pojava novog, besplatnog metričkog pokazatelja, SCImago Journal Ranka [PDF]

Kemija u Industriji, 2008
Macan, B.
doaj  

2024 impact factor increases again and submissions up ~30. [PDF]

Optom Vis Sci
Elliott DB.
europepmc   +1 more source

The analysis of common cause failure based on impact vector considering human factor diversity

, 2013
In the redundant system, Common Cause Failure (CCF) can result in failures of more than one module. Human Error is one of the most important causes among all the causes of CCF. Human factor diversity is an effective method against CCF due to human error.
Liu J(刘捷), Xu AD(徐皑冬), Wang K(王锴), Wang H(王宏)   +3 more
core  

Establishment of a humanized patient‐derived xenograft mouse model of high‐grade serous ovarian cancer for preclinical evaluation of combination immunotherapy

Molecular Oncology, EarlyView.
We have established a humanized orthotopic patient‐derived xenograft (Hu‐oPDX) mouse model of high‐grade serous ovarian cancer (HGSOC) that recapitulates human tumor–immune interactions. Using combined anti‐PD‐L1/anti‐CD73 immunotherapy, we demonstrate the model's improved biological relevance and enhanced translational value for preclinical ...
Luka Tandaric, Line Bjørge, Martine Rott Lode, Cecilie Fredvik Torkildsen, Pia Aehnlich, Rammah Elnour, Daniela Elena Costea, Lars Andreas Akslen, Liv Cecilie Vestrheim Thomsen, Emmet McCormack, Katrin Kleinmanns   +10 more
wiley   +1 more source

Are the Editors Responsible for Our Obsession with the Impact Factor?

mBio, 2017
Juan Carlos Argüelles, Raquel Argüelles-Prieto   +1 more
doaj   +1 more source

Impact Factor Evolution of Clinical Neuroradiology. [PDF]

Clin Neuroradiol, 2023
Bendszus M.
europepmc   +1 more source

Substitution in Markusen's classic trade and factor movement complementarity models [PDF]

Mundell and Markusen each wrote classic papers on the relationship between trade and factor movement. Mundell showed that substitution holds in the Heckscher-Ohlin model.
Schiff, Maurice
core  

Hippo pathway at the crossroads of stemness and therapeutic resistance in breast cancer

Molecular Oncology, EarlyView.
Dysregulation of the Hippo pathway drives nuclear accumulation of YAP/TAZ, activating stemness‐related transcriptional programs that sustain breast cancer stemness and fuel therapeutic resistance across subtypes, underscoring Hippo signaling as a targetable vulnerability. Figure created and edited with BioRender.com.
Giulia Schiavoni, Antonella Palmese, Stefano Scalera, Laura Cipriani, Davide Mascolo, Patrizia Vici, Teresa Arcuri, Lorena Filomeno, Eriseld Krasniqi, Giovanni Blandino, Giulia Bon, Marcello Maugeri‐Saccà   +11 more
wiley   +1 more source